Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The intersection of nonalcoholic fatty liver disease and obesity
Jennifer A. Woo Baidal, Joel E. Lavine
Science Translational Medicine (2016) Vol. 8, Iss. 323
Closed Access | Times Cited: 73

Showing 26-50 of 73 citing articles:

Medium-chain fatty acids suppress lipotoxicity-induced hepatic fibrosis via the immunomodulating receptor GPR84
Ryuji Ohue‐Kitano, Hazuki Nonaka, Akari Nishida, et al.
JCI Insight (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 21
B-Type Trimeric Procyanidins Attenuate Nonalcoholic Hepatic Steatosis Through AMPK/mTOR Signaling Pathway in Oleic Acid-Induced HepG2 Cells and High-Fat Diet- Fed Zebrafish
Fangfang Tie, Yidan Gao, Lichengcheng Ren, et al.
Plant Foods for Human Nutrition (2025) Vol. 80, Iss. 1
Open Access
Nicotinic acetylcholine receptor α7 subunit improves energy homeostasis and inhibits inflammation in nonalcoholic fatty liver disease
Dongjie Li, Jian Liu, Hua Xia, et al.
Metabolism (2017) Vol. 79, pp. 52-63
Open Access | Times Cited: 37
Effects of piperine on lipid metabolism in high-fat diet induced obese mice
Yafang Du, Yuzhong Chen, Xiaoya Fu, et al.
Journal of Functional Foods (2020) Vol. 71, pp. 104011-104011
Open Access | Times Cited: 29
Therapeutic Opportunities of IL-22 in Non-Alcoholic Fatty Liver Disease: From Molecular Mechanisms to Clinical Applications
Wenjing Zai, Wei Chen, Hongrui Liu, et al.
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1912-1912
Open Access | Times Cited: 25
Systematic review and meta‐analysis: non‐invasive detection of non‐alcoholic fatty liver disease related fibrosis in the obese
Geraldine Ooi, S. Mgaieth, Guy D. Eslick, et al.
Obesity Reviews (2017) Vol. 19, Iss. 2, pp. 281-294
Open Access | Times Cited: 29
Growing burden of nonalcoholic fatty liver disease in Turkey: A single-center experience
Yusuf Yılmaz, Haluk Tarık Kani, Coşkun Özer Demirtaş, et al.
The Turkish Journal of Gastroenterology (2019) Vol. 30, Iss. 10, pp. 892-898
Open Access | Times Cited: 29
Dietary pattern and hepatic lipid metabolism
Peng Zou, Lin Wang
Liver Research (2023) Vol. 7, Iss. 4, pp. 275-284
Open Access | Times Cited: 8
Loss of immunity-related GTPase GM4951 leads to nonalcoholic fatty liver disease without obesity
Zhao Zhang, Yu Xun, Shunxing Rong, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Wulingsan Alleviates MAFLD by Activating Autophagy via Regulating the AMPK/mTOR/ULK1 Signaling Pathway
Yaning Biao, D. Li, Yixin Zhang, et al.
Canadian Journal of Gastroenterology and Hepatology (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 2
Current strategies for nonalcoholic fatty liver disease treatment (Review)
Jing Sun, Xiuli Jin, Yiling Li
International Journal of Molecular Medicine (2024) Vol. 54, Iss. 4
Open Access | Times Cited: 2
A charge reversal nano-assembly prevents hepatic steatosis by resolving inflammation and improving lipid metabolism
H. Wang, Shenge Su, Xin An, et al.
Bioactive Materials (2024) Vol. 45, pp. 496-508
Closed Access | Times Cited: 2
Prevalence of hepatic steatosis in apparently healthy medical students: a transient elastography study on the basis of a controlled attenuation parameter
Eda Kaya, Dogac Demir, Yeşim Özen Alahdab, et al.
European Journal of Gastroenterology & Hepatology (2016) Vol. 28, Iss. 11, pp. 1264-1267
Closed Access | Times Cited: 22
Structure–function relationship analysis of fucoidan from sea cucumber ( Holothuria tubulosa ) on ameliorating metabolic inflammation
Yujie Zhu, Yingying Tian, Na Wang, et al.
Journal of Food Biochemistry (2020) Vol. 45, Iss. 1
Open Access | Times Cited: 19
Bacterial antigen translocation and age as BMI‐independent contributing factors on systemic inflammation in NAFLD patients
Isabel Gómez‐Hurtado, Rocío Gallego‐Durán, Pedro Zapater, et al.
Liver International (2020) Vol. 40, Iss. 9, pp. 2182-2193
Closed Access | Times Cited: 17
Elimination of fibrin polymer formation or crosslinking, but not fibrinogen deficiency, is protective against diet‐induced obesity and associated pathologies
Woosuk S. Hur, Katharine C. King, Yesha N. Patel, et al.
Journal of Thrombosis and Haemostasis (2022) Vol. 20, Iss. 12, pp. 2873-2886
Open Access | Times Cited: 9
The hepatic integrated stress response suppresses the somatotroph axis to control liver damage in nonalcoholic fatty liver disease
Rika Ohkubo, Wei‐Chieh Mu, Chih-Ling Wang, et al.
Cell Reports (2022) Vol. 41, Iss. 11, pp. 111803-111803
Open Access | Times Cited: 9
Effect of adipocyte-secreted factors on EpCAM+/CD133+ hepatic stem cell population
Zeynep Fırtına Karagonlar, Doğukan Koç, Eren Şahin, et al.
Biochemical and Biophysical Research Communications (2016) Vol. 474, Iss. 3, pp. 482-490
Closed Access | Times Cited: 13
CDKN2A deregulation in fatty liver disease and its accelerative role in the process of lipogenesis
Zhi Zhang, Huiqing Wen, Bangjian Peng, et al.
The FASEB Journal (2021) Vol. 35, Iss. 4
Closed Access | Times Cited: 12
β2-Adrenergic Receptor Agonist Induced Hepatic Steatosis in Mice: Modeling Nonalcoholic Fatty Liver Disease in Hyperadrenergic States
Yun Shi, Jason Pizzini, Hanzhou Wang, et al.
AJP Endocrinology and Metabolism (2021)
Open Access | Times Cited: 12
Functional loss of inactive rhomboid-like protein 2 mitigates obesity by suppressing pro-inflammatory macrophage activation-triggered adipose inflammation
Minxuan Xu, Chenxu Ge, Yuting Qin, et al.
Molecular Metabolism (2020) Vol. 34, pp. 112-123
Open Access | Times Cited: 12
Association between hemoglobin glycation index and non-alcoholic fatty liver disease
Yuling Xing, Yunfeng Zhen, Liqun Yang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 4
Development and Validation of a Risk Prediction Model for NAFLD: A Study Based on a Physical Examination Population
Chunmei Yang, Tingwan Du, Yueying Zhao, et al.
Diabetes Metabolic Syndrome and Obesity (2024) Vol. Volume 17, pp. 143-155
Open Access | Times Cited: 1
Placental growth factor deficiency initiates obesity- and aging-associated metabolic syndrome
Ji Hee Lim, Yaeni Kim, Min Young Kim, et al.
Metabolism (2024) Vol. 161, pp. 156002-156002
Closed Access | Times Cited: 1
UBE3A Suppresses Overnutrition‐Induced Expression of the Steatosis Target Genes of MLL4 by Degrading MLL4
Jang‐Hyun Kim, Bora Lee, Dae‐Hwan Kim, et al.
Hepatology (2018) Vol. 69, Iss. 3, pp. 1122-1134
Open Access | Times Cited: 10

Scroll to top